Washington, D.C.–U.S. Senate Finance Committee Chairman Mike Crapo (R-Idaho) and Finance Committee member Michael Bennet (D-Colorado), with Ranking Member Ron Wyden (D-Oregon) and Finance Committee member Tim Scott (R-South Carolina), reintroduced the Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act that would ensure Medicare beneficiaries’ access to cutting-edge tests capable of detecting multiple types of cancer before symptoms appear. Bipartisan companion legislation (H.R. 842) was also introduced in the U.S. House of Representatives. Continue reading
Author Archive: AZBio
TGen researchers create spatial map of gene expression in pulmonary fibrosis
Unique look revealed signs of disease prior to lung remodelingContinue reading
XLR8 PBC Applications Open for Scale-Ready Health Tech Companies; Esteemed Mentor Lineup Announced
Phoenix, AZ – XLR8 PBC, Arizona’s premier program for scale-ready health tech companies, is now accepting applications for its latest cohort. With a no-cost, no-equity structure, XLR8 PBC provides health tech companies with unparalleled access to industry leaders, mentorship, and strategic resources. Applications for the program are open until February 19, 2025, offering founders the opportunity to engage with a world-class team of mentors and position their ventures for accelerated growth.Continue reading
Flinn-Brown application opens. Apply by Feb. 28
The Flinn-Brown Fellowship is a statewide civic leadership program like no other.Continue reading
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
— JOURNAVX is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than 20 years —
— JOURNAVX is an effective and well-tolerated medicine without evidence of addictive potential indicated for use across all types of moderate-to-severe acute pain —Continue reading
Lisanby named founding dean of new ASU medical school
Internationally acclaimed innovator to ‘reengineer the future of health’ in new role
Pending accreditation, ASU’s School of Medicine and Advanced Medical Engineering is expected to begin enrolling students later this year and open in fall 2026. Continue reading
Clinical study explores regenerative therapy for epilepsy
Mayo Clinic is participating in the first in-human investigation of regenerative therapy for the treatment of drug-resistant epilepsy. The multicenter study will test the safety of implanting interneurons into the hippocampus in patients with the disease. Future studies are planned to investigate the potential for these cells to restore normal excitatory-inhibitory balance.Continue reading
HonorHealth announces the creation of its new international Center for Translational Science
The new center is seen as a worldwide bridge among scientists, researchers and physicians in their pursuit of new diagnostics and therapeutics to benefit patientsContinue reading
Anivive Secures $20 Million Investment from Leonid Capital Partners to Develop the Next Generation of Pet Health
Funding expands manufacturing readiness for Valley fever vaccine. This follows Anivive’s $33MM NIAID contract for fungal vaccines
In total, Anivive has secured over $80MM in contracts and preordersContinue reading
ASU Releases Report on Economic Impact
Report shows ASU is a major economic engine driving the state through investments, spinoffs, research, taxes paid by alumni and more.Continue reading